Skip to main content

Table 2 Cholesterol-lowering medications used and their effects on cholesterol levels (P-value)

From: Potential impact of high-density lipoprotein cholesterol in the postoperative outcomes of chronic subdural hematoma patients: multi-institutional study in Korea

 

Number of patients

TC

HDL-C

LDL-C

TG

Atorvastatin

37

0.382

0.993

0.378

0.418

Rosuvastatin

18

0.723

0.698

0.534

0.646

Combined

11

0.524

0.004*

0.187

0.548

Pitavastatin

8

0.053

0.984

0.012*

0.617

Simvastatin

3

0.994

0.759

0.321

0.660

Fenofibrate

2

0.882

0.244

0.406

0.828

Ezetimibe

1

0.767

0.495

 N/A

0.739

Fluvastatin

1

N/A

N/A

N/A

N/A

N/A

31

0.217

0.282

0.379

0.088

Total

112

    
  1. TC: total cholesterol, HDL-C: high-density lipoprotein cholesterol, LDL-C: low-density lipoprotein cholesterol, TG: triglycerides, N/A: not available; *P-value < 0.05
Back to article page

Lipids in Health and Disease

ISSN: 1476-511X